Autoantibody Against Oxidised LDL and Progression of Carotid Atherosclerosis
Lancet 339:883-900, Salonen,J.T.,et al, 1992
Antibodies to Oxidised LDL in Atherosclerosis
Editorial, Lancet 339:899-9001992., , 1992
Regression of Carotid Plaques During Low Density Lipoprotein Cholesterol Elimination
Stroke 22:989-992, Hennerici,M.,et al, 1991
Prediction of Carotid Stenosis Progression by Lipid & Hematologic Measurements
Neurol 39:1325-1331, Grotta,J.C.,et al, 1989
Cholesterol Lowering and Prevention of Stroke
Stroke 50:537-541, Hackam, D.G. & Hegele, R.A., 2019
Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study
Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008
Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005
Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004
HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000
Distribution of Atherosclerosis and Risk Factors in Atherothrombotic Occlusion
Stroke 24:206-211, Yasaka,M.,et al, 1993